Page last updated: 2024-10-26

disopyramide and Obesity

disopyramide has been researched along with Obesity in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms."2.61Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy. ( Fischer, KL; Heitner, SB, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heitner, SB1
Fischer, KL1

Reviews

1 review available for disopyramide and Obesity

ArticleYear
Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
    Cardiology clinics, 2019, Volume: 37, Issue:1

    Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiotonic Age

2019